Course Detail

Integrating Harm Reduction into Every Clinical Encounter

Details

Published Date: 02/26/2024

Expiration Date: 10/31/2026

CE Credit: CME:1CNE: 1CPE: 1

Description

This course will discuss the importance of having a harm reduction approach to effectively reduce the risk of overdose and decrease the transmission of blood borne viruses and other negative health outcomes associated with substance use. At the end of this course clinicians will be able to identify three harm reduction principles to guide their practice, identify three Hepatitis C prevention strategies, and utilize “elicit, provide, elicit” as a tool for delivering patient-centered health education.

Presenter(s)

Andrew Reynolds

Andrew Reynolds is the Hepatitis C Wellness Manager at the San Francisco AIDS Foundation and an independent hepatitis C and harm reduction consultant and is the former Hepatitis C and Harm Reduction Manager for Project Inform. In these roles, he writes health education materials, fact sheets, toolkits and articles on all aspects of hepatitis C awareness, prevention and treatment, and he also works in viral hepatitis and drug user health policy and advocacy. He is the Hepatitis C Editor for Positively Aware, and the author of the magazine’s “Annual Hepatitis C Drug Guide,” and sits on the AASLD/IDSA HCV Guidance Panel. Andrew has over 20 years of HCV, HIV and STD awareness, prevention and treatment experience, delivered in a wide variety of settings from street outreach to clinical settings to jails and prisons. In addition to HCV, Andrew works extensively in drug user health, harm reduction and safe consumption space education and advocacy. He serves on numerous boards of directors, advisory boards and committees, including the Organizing Committee of the “End the Epidemics” campaign for California, a community initiative to eliminate HIV, HCV and STDs in California.

Linda Wang,MD

Linda Wang, MD is a general internist and addiction medicine specialist who cares for people who use drugs at the REACH Program at Mount Sinai, where she also directs the buprenorphine treatment program. She received her medical degree from the Icahn School of Medicine at Mount Sinai and completed internal medicine residency and chief residency in the Primary Care and Social Internal Medicine Program at Montefiore Medical Center in the Bronx. She is the Medical Director for the Mount Sinai Hepatitis C and Drug User Health Center of Excellence, which is funded by the New York State Department of Health AIDS Institute. She is the Chair of the New York State Drug User Health Working Group. She is an active clinician educator who is interested in expanding access to substance use disorder treatment, providing stigma-free care for people who use drugs, and training current and future clinicians in drug user health.

Learning Objectives

Discuss the guiding principles of harm reduction in the context of working with individuals who use drugs.
Describe harm reduction techniques and communication skills that clinicians can employ in their practice.
Identify the ways that harm reduction approaches can improve patient engagement and clinical outcomes.
Describe common barriers and methods to overcome them when delivering clinical care to people who use drugs.

Continuing Education Credit Information

Learn more and Enroll